Literature DB >> 21263083

Should oncologists be aware in their clinical practice of KRAS molecular analysis?

Daniele Santini, Sara Galluzzo, Laura Gaeta, Alice Zoccoli, Elisabetta Riva, Annamaria Ruzzo, Bruno Vincenzi, Francesco Graziano, Fotios Loupakis, Alfredo Falcone, Andrea Onetti Muda, Giuseppe Tonini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21263083     DOI： 10.1200/JCO.2010.32.7700

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients.

Authors:  Bruno Vincenzi; Chiara Cremolini; Andrea Sartore-Bianchi; Antonio Russo; Francesco Mannavola; Giuseppe Perrone; Francesco Pantano; Fotios Loupakis; Daniele Rossini; Elena Ongaro; Erica Bonazzina; Emanuela Dell'Aquila; Marco Imperatori; Alice Zoccoli; Giuseppe Bronte; Giovanna De Maglio; Gabriella Fontanini; Clara Natoli; Alfredo Falcone; Daniele Santini; Andrea Onetti-Muda; Salvatore Siena; Giuseppe Tonini; Giuseppe Aprile
Journal:  Oncotarget       Date:  2015-10-13

2.  Low percentage of KRAS mutations revealed by locked nucleic acid polymerase chain reaction: implications for treatment of metastatic colorectal cancer.

Authors:  Mariella Dono; Carlotta Massucco; Silvana Chiara; Claudia Sonaglio; Marco Mora; Anna Truini; Giannamaria Cerruti; Gabriele Zoppoli; Alberto Ballestrero; Mauro Truini; Manlio Ferrarini; Simona Zupo
Journal:  Mol Med       Date:  2013-02-08       Impact factor: 6.354

3.  KRAS mutation detection by high-resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer.

Authors:  U Malapelle; C Carlomagno; M Salatiello; A De Stefano; C De Luca; R Bianco; R Marciano; C Cimminiello; C Bellevicine; S De Placido; G Troncone
Journal:  Br J Cancer       Date:  2012-07-17       Impact factor: 7.640

4.  Predictive Molecular Tumour Testing: What Are the Obstacles between Bench and Bedside?

Authors:  Linda Mileshkin; Bhaumik Shah; Michael Michael
Journal:  Chemother Res Pract       Date:  2012-05-14

5.  Improved detection of BRAF V600E using allele-specific PCR coupled with external and internal controllers.

Authors:  Zhao Yang; Na Zhao; Dong Chen; Kun Wei; Ning Su; Jun-Fu Huang; Han-Qing Xu; Guang-Jie Duan; Wei-Ling Fu; Qing Huang
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.